Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
NCT06323681
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
2016
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis b
Interventions
DRUG:
Peginterferon α-2b based treatment group
DRUG:
NAs monotherapy group
Sponsor
Qing XIe